Previous studies have been conflicting or limited by small numbers or single-country ascertainment.18,22,29 The recent ACMG review and clinical guidance for CHEK2 heterozygotes2 did not find sufficient evidence to support a clear association for thyroid cancer and did not recommend surveillance. This evidence concerns the gene CHEK2 and thyroid cancer.